Journal Information
Vol. 83. Issue 6.
Pages 732 (November - December 2017)
Vol. 83. Issue 6.
Pages 732 (November - December 2017)
Letter to the Editor
Open Access
The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss
O papel da oxigenoterapia hiperbárica e da ozonioterapia na perda súbita de audição
Visits
7985
Serkan Ergözen
ASAL Hyperbaric Oxygen Treatment Center, Yunus Emre Mah, Ankara, Turkey
Related content
Braz J Otorhinolaryngol. 2017;83:457-6310.1016/j.bjorl.2016.06.002
Gülin Ergun Taşdöven, Alper Tunga Derin, Neslihan Yaprak, Hasan Ümit Özçağlar
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

I’ve read the valuable article entitled “The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss” by Gülin Ergun Taşdöven et al.1 In this article, the authors mentioned that the cost of Hyperbaric Oxygen Therapy (HBOT) for Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) was not met by any insurance company. However, this information is incorrect, so I would like to give some information about the payment list of the Government Social Security System (GSSS) in Turkey.

An indication list of payments covered by GSSS is published every year in Turkey. The inclusion criteria for payments are also included on the list.

ISSNHL is one of the indications which has been paid for by the Turkish social security system for years, including 2010. In 2010, the GSSS criteria was “The patient must begin hyperbaric oxygen therapy within one month of the diagnosis of ISSNHL. These patients are administered a weekly audiological test. If the hearing gain is <10dB (pure tone average) after two weeks of treatment (10 sessions), subsequent sessions will not be paid for but if the hearing gain is equal to or higher than 10dB, 30 more sessions can be paid for by GSSS”.2 The criteria in use since 2012 is “ISSNHL must be diagnosed by audiological test in the last 30 days. If the hearing gain is <20dB (pure tone average) after the 20th session of treatment, subsequent sessions will not be paid for but if the hearing gain is equal to or higher than 20dB, 20 more sessions will be paid for by GSSS”.3

In addition to the GSSS payment, private HBOT clinics in Turkey can request an extra fee for each session, which may vary between 0 and 15 U.S. dollars. For example, patients pay only 2.5 USD extra fee for each session in our clinic.

Apart from ISSNHL, the GSSS and some private insurance companies pay for HBOT for the indications of decompression sickness, air or gas embolism, carbonmonoxide poisoning, cyanide poisoning, acute smoke inhalation, gas gangrene, necrotizing soft tissue infections, crush injuries, compartment syndrome, acute traumatic ischemia, diabetic and non-diabetic chronic wounds, chronic refractory osteomyelitis, radiation necrosis, compromised flaps and grafts, thermal injuries, brain abscess, anoxic encephalopathy, retinal artery occlusion, acute osteomyelitis of skull–sternum–vertebrate, and avascular necrosis of bone.3

Conflicts of interest

The author declares no conflicts of interest.

References
[1]
G. Ergun Taşdöven, A.T. Derin, N. Yaprak, H.Ü. Özçağlar.
The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss.
Braz J Otorihinolaryngol, (2016),

Please cite this article as: Ergözen S. The place of hyperbaric oxygen therapy and ozone therapy in sudden hearing loss. Braz J Otorhinolaryngol. 2017;83:732.

Copyright © 2017. Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial
Idiomas
Brazilian Journal of Otorhinolaryngology (English Edition)
Article options
Tools
en pt
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.